Search

UQ's Vice-Chancellor and President, Professor Peter Høj

A message from Professor Peter Høj, discussing research translation and commercialisation.

Thursday, 13 August 2015 - 10:30am
UQ's Dr Leigh Ward

More cancer patients will now have access to early lymphedema detection technology, with a product developed by publicly listed medical device company Impedimed Limited (

Thursday, 13 August 2015 - 9:45am
UQ's Associate Professor Mark Smythe

In 2014, Protagonist Therapeutics, Inc.

Thursday, 13 August 2015 - 9:30am
Emory University's Dennis Liotta

QUE Oncology, Inc. is developing novel therapies to address unmet medical needs in the treatment of cancer and its consequences.

Thursday, 13 August 2015 - 9:15am

Pharmaceutical company AstraZeneca and UniQuest have formed an "open innovation" program to support academic and clinical research that holds the promise of fin

Monday, 10 August 2015 - 10:30am
UQ's Professor Matt Brown

UniQuest has entered into an R&D and license agreement with Janssen Cilag, (Janssen) to identify, develop and commercialise small molecule modulators of a biological

Monday, 10 August 2015 - 10:15am

The University of Queensland has made a commitment to the discovery and development of new therapeutic drugs, supporting the establishment of the Queensland Emory Drug Di

Monday, 10 August 2015 - 10:00am
UQ's Professor Ian Frazer

Under the guidance of Professor Ian Frazer, the co-inventor of the Gardasil cervical cancer vaccine, Admedus Vaccines is now focused on a technology for improving immune

Monday, 10 August 2015 - 8:15am

Pages